Visby Medical’s COVID-19 PCR Point of Care Test Authorized for Use in CLIA Waived Settings

SAN JOSE, Calif., Feb. 10, 2021 /PRNewswire/ — Visby Medical™ announced today the US Food and Drug Administration (FDA) authorized Visby’s rapid PCR COVID-19 test for use at the point of care (POC). Building on the FDA’s emergency use authorization granted earlier this year, Visby…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.